Maxonis

Maxonis is a biotechnology company developing LDP-916 (AGRG), a next-generation regenerative gel for Peripheral Nerve Injury (PNI) and Spinal Cord Injury (SCI). Based on 15+ years of research at Tel Aviv Sourasky Medical Center, LDP-916 uses four FDA-recognized materials to guide axonal regrowth an... Read more